Vaniprevir

伐尼瑞韦

Report date: 2022/08/17 14:30:32
NME

Base Information

Drug NameVaniprevir
Drug Alias NamevaniprevirvaniprevirumVanihepMK-7009
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitors
TargetsHepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsHepatitis C, ChronicHepatitis C
Global Approved IndicationsHepatitis C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2014/09/26
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme Corp
Inactive CompaniesMerck & Co IncMerck Sharp & Dohme LLC
Active IndicationsHepatitis C
Inactive IndicationsHepatitis C, Chronic

Other Information

ATC CodeJ05AP
Related LinksWikipediaKEGG